Rhythm Pharmaceuticals Stock Forecast - Accumulation Distribution

RYTM Stock  USD 67.33  3.43  5.37%   
Rhythm Stock Forecast is based on your current time horizon. Although Rhythm Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Rhythm Pharmaceuticals' systematic risk associated with finding meaningful patterns of Rhythm Pharmaceuticals fundamentals over time.
  
At this time, Rhythm Pharmaceuticals' Payables Turnover is very stable compared to the past year. As of the 11th of November 2024, Fixed Asset Turnover is likely to grow to 38.31, while Inventory Turnover is likely to drop 1.02. . As of the 11th of November 2024, Common Stock Shares Outstanding is likely to drop to about 39.3 M. In addition to that, Net Loss is likely to grow to about (154.9 M).
Rhythm Pharmaceuticals has current Accumulation Distribution of 0.07. The accumulation distribution (A/D) indicator shows the degree to which Rhythm Pharmaceuticals is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Rhythm Pharmaceuticals to determine if accumulation or reduction is taking place in the market. This value is adjusted by Rhythm Pharmaceuticals trading volume to give more weight to distributions with higher volume over lower volume.
Check Rhythm Pharmaceuticals VolatilityBacktest Rhythm PharmaceuticalsInformation Ratio  

Rhythm Pharmaceuticals Trading Date Momentum

On November 11 2024 Rhythm Pharmaceuticals was traded for  67.33  at the closing time. The top price for the day was 67.61  and the lowest listed price was  62.88 . There was no trading activity during the period 0.0. Lack of trading volume on November 11, 2024 did not cause price change. The trading delta at closing time against the current closing price is 6.33% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Rhythm Pharmaceuticals to competition

Other Forecasting Options for Rhythm Pharmaceuticals

For every potential investor in Rhythm, whether a beginner or expert, Rhythm Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rhythm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rhythm. Basic forecasting techniques help filter out the noise by identifying Rhythm Pharmaceuticals' price trends.

View Rhythm Pharmaceuticals Related Equities

 Risk & Return  Correlation

Rhythm Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Rhythm Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Rhythm Pharmaceuticals' current price.

Rhythm Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Rhythm Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rhythm Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rhythm Pharmaceuticals stock market strength indicators, traders can identify Rhythm Pharmaceuticals entry and exit signals to maximize returns.

Rhythm Pharmaceuticals Risk Indicators

The analysis of Rhythm Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rhythm Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rhythm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Rhythm Pharmaceuticals is a strong investment it is important to analyze Rhythm Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rhythm Pharmaceuticals' future performance. For an informed investment choice regarding Rhythm Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Rhythm Pharmaceuticals to cross-verify your projections.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.32)
Revenue Per Share
1.863
Quarterly Revenue Growth
0.478
Return On Assets
(0.46)
Return On Equity
(1.48)
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.